The influence of hippocampal dopamine D2 receptor losses on episodic-memory decline across 5 years is moderated by BDNF and KIBRA polymorphisms
Cortex · 2024
DOI: 10.1016/j.cortex.2024.01.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cortex, 2024. Verfasst von Goran Papenberg und 8 weiteren Autor:innen. Beteiligte Einrichtung: Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden. Electronic address: goran.papenberg@ki.se. Hauptthemen laut MEDLINE: Receptors, Dopamine D2, Memory, Episodic, Hippocampus, Brain-Derived Neurotrophic Factor. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council.
Abstract (Originalsprache)
Losses in dopamine (DA) functioning may contribute to aging-related decline in cognition. Hippocampal DA is necessary for successful episodic memory formation. Previously, we reported that higher DA D2 receptor (D2DR) availability in hippocampus is beneficial for episodic memory only in older carriers of more advantageous genotypes of well-established plasticity-related genetic variations, the brain-derived neurotrophic factor (BDNF, rs6265) and the kidney and brain expressed protein (KIBRA, rs17070145) polymorphisms. Extending our observations to the longitudinal level, the current data show that individuals with one or no beneficial BDNF and KIBRA genotype (n = 80) decline more in episodic memory across five years, without any contribution of losses in hippocampal D2DR availability to memory decline. Although carriers of two beneficial genotypes (n = 39) did not decline overall in episodic memory, losses of hippocampal D2DR availability were predictive of episodic-memory decline among these individuals. Our findings have implications for interventions targeting DA modulation to enhance episodic memory in aging, which may not benefit all older individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden. Electronic address: goran.papenberg@ki.se.
- Umeå Center for Functional Brain Imaging (UFBI), Umeå University, Umeå, Sweden; Department of Medical and Translational Biology, Umeå University, Umeå, Sweden.
- Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden; Umeå Center for Functional Brain Imaging (UFBI), Umeå University, Umeå, Sweden.
- Center for Lifespan Psychology, Max Planck Institute for Human Development, Berlin, Germany; Max Planck UCL Centre for Computational Psychiatry and Ageing Research, Berlin, Germany.
- Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden; Umeå Center for Functional Brain Imaging (UFBI), Umeå University, Umeå, Sweden; Department of Medical and Translational Biology, Umeå University…
- Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
Förderung
- Swedish Research Council
Zitieren
APA
Papenberg, G., Karalija, N., Johansson, J., Andersson, M., Axelsson, J., Riklund, K., Lindenberger, U., Nyberg, L., & Bäckman, L. (2024). The influence of hippocampal dopamine D2 receptor losses on episodic-memory decline across 5 years is moderated by BDNF and KIBRA polymorphisms. Cortex. https://doi.org/10.1016/j.cortex.2024.01.014
Vancouver
Papenberg G, Karalija N, Johansson J, Andersson M, Axelsson J, Riklund K, et al. The influence of hippocampal dopamine D2 receptor losses on episodic-memory decline across 5 years is moderated by BDNF and KIBRA polymorphisms. Cortex. 2024. doi:10.1016/j.cortex.2024.01.014
BibTeX
@article{Papenberg2024,
author = {Papenberg, Goran and Karalija, Nina and Johansson, Jarkko and Andersson, Micael and Axelsson, Jan and Riklund, Katrine and Lindenberger, Ulman and Nyberg, Lars and Bäckman, Lars},
title = {The influence of hippocampal dopamine D2 receptor losses on episodic-memory decline across 5 years is moderated by BDNF and KIBRA polymorphisms},
journal = {Cortex},
year = {2024},
doi = {10.1016/j.cortex.2024.01.014}
}
EUVIMED